Barr Challenges Aventis’ Nasacort Patents
This article was originally published in The Pink Sheet Daily
Aventis filed suit in Delaware federal court to block Barr from proceeding with a generic of the nasal allergy spray.
You may also be interested in...
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Merger will create the leading generic injectable pharmaceutical company in the world.
Amgen CEO gets early promotion.